MO781THE CATIONIC CELLULOSE BASED PAD REDUCE THE HEMOSTATIC TIME AFTER HEMODIALYSIS

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Kazuhiko Shibata ◽  
Shigeru Nakai ◽  
Yusuke Kobayashi ◽  
Kiyoshi Ozawa ◽  
Koichi Tamura

Abstract Background and Aims In case of prolonged bleeding at the vascular access site after hemodialysis, a nurse must compress the bleeding site longer than usual. This situation causes the risk of intravascular thrombosis and consumes valuable time of both patients and staff. Therefore, effective hemostatic agents are desired. Nowadays, chitosan is considered as one of the strongest hemostatic substance. Nipro Corporation and Artisan-lab co., Ltd found the cationic cellulose could clot blood faster than chitosan in the activated clotting time (Figure). After carefully examining its safety and efficacy, it was approved as medicine by the Japanese Ministry of Health, Labor and Welfare. Then, a trial to verify its clinical efficacy as a hemostat was conducted in the Toshin Clinic. In our clinic, the timer is set on the hemodialysis machine after the needles are removed and pressure is started after hemodialysis. We examined how long the timer should be set to be able to sufficiently stop bleeding in case cationic-cellulose pads are used. Method Of the 150 hemodialysis patients treated at the Toshin clinic; patients who agreed to this trial were enrolled. We set a timer for 5 minutes initially using cationic-cellulose pads for hemostasis, and was shortened in the next trial by 1 minute if the bleeding had been stopped. If the patient did not consent, the timer was not shortened further. from April 15th to December 31st in 2020. We checked the bleeding evidence of the puncture sites at the timing of immediately after relieving their compression. At their following hemodialysis session, we also checked the existence of adverse effects at their puncture sites, such as contact dermatitis or infection. Results Ten patients (9 men and 1 woman, Age 58.5y ±13.1) agreed to participate in this study. In the case of stable hemostasis, we continued to shorten the time by 1 minute each time, and added 1 minute in case of bleeding. After searching for the shortest time to achieve stable hemostasis, we confirmed hemostasis an average of 14.2 times in all cases. The average time to set for the timer was 3.0 ± 0.94 minutes (2-5 minutes). Two patients refused to shorten the time set for the timer, the hemostasis time were 5 and 4minutes respectively. The hemostasis time in all the other cases was equal or less than 3 minutes. In one case, the hemostasis time was reduced to 3 minutes with a cationic cellulose pad, compared to 30 minutes with The Neoplaster hemostatic pad (Nipro Corporation) which is made with the carboxymethyl cellulose. Of the 142 case compressions performed, 1 case resulted in bleeding and required 2 minutes of additional compressions. All cases did not have any adverse effects such as redness, itching or pain of their hemostatic pad attached sites. Discussion This study showed that the average time to set for the timer, when using cationic cellulose pad was 3 minutes on average, without any adverse effects. Cationic cellulose pads can stop bleeding safely, quickly and stably. At present, clinically available strong hemostatic agents are too expensive to be applied for many patients. But the cost to get the cationic-cellulose to make hemostatic pads may be reduced enough to be distributed to many hemodialysis patients because this material is mass-produced for hair conditioner, shampoo, and toothpaste. Conclusion The average time set for the timer was estimated around 3 minutes using the cationic cellulose pad. The cationic cellulose pad can save precious time and efforts of both patients and staff through its quick hemostasis.

2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Kazuhiko Shibata ◽  
Hirokazu Morita ◽  
Mitsutaka Ueda ◽  
Shigeru Nakai

Abstract Background and Aims In case of prolonged bleeding at the vascular access site after hemodialysis, a nurse must compress the bleeding site longer than usual. This situation causes the risk of intravascular thrombosis and consumes valuable time of both patients and staff. Therefore, the method that can surely stop bleeding from the puncture site in short time is desired. Nowadays, chitosan is considered as one of the strongest hemostatic substance. Nipro Corporation and Artisan-lab co.,Ltd found the cationic cellulose could clot blood faster than chitosan in the activated clotting time (ACT). After carefully examining its safety and efficacy, it was approved as medicine by the Japanese Ministry of Health, Labor and Welfare. Then, a trial to verify its clinical efficacy as a hemostat was conducted in the Yokohama Minami Clinic. Method 150 hemodialysis patients treated at the Yokohama Minami Clinic excluding those using catheters or having with good hemostasis were selected as candidates for this study. 127 patients (64 men and 63 women) among them agreed to participate in this study after our explanation. 547 times of 5 minutes’ compression hemostasis were performed to the patients using cationic-cellulose pads for hemostasis from December 29th in 2019 to January 3rd in 2020. We checked the bleeding evidence of the puncture sites at the both timing of immediately after relieving their compression and the start of the following session. At their following session starting, we also checked the existence of adverse effects at their puncture sites, such as contact dermatitis or infection. Results Five of 547 cases (0.9%) had bleeding immediately after their compression relieving, and they needed to prolong their compression (the average of prolongation time was 3.0 minutes). But the other 542 cases (99.1%) successfully stopped bleeding within 5 minutes. All cases except two cases with redness at the adhesive tape attached site did not have any adverse effects such as redness, itching or pain of their hemostatic pad attached sites, including one case who forgot to remove his hemostatic pad until 48 hours later. The nurses could reduce their efforts to check the patients’ hemostasis and work smoother than usual, throughout this study period. Discussion In most cases of this study, the cationic-cellulose pad could stop bleeding within 5 minutes without any adverse effects. This result suggests that this material has sufficient performance for clinical use. The cationic-cellulose used for the hemostatic pads in this study had already had high enough quality for clinical use and it was produced by Kao Corporation. At present, clinically available strong hemostatic agents are too expensive to be applied for every patient. But the cost to get the cationic-cellulose to make hemostatic pads may be reduced enough low to be distributed to all hemodialysis patients because this material is mass-produced for hairdressing agent. Conclusion The cationic cellulose pad can save precious time and efforts of both patients and staff through its quick hemostasis. Figure The cationic cellulose pad


2021 ◽  
Vol 30 ◽  
pp. S219
Author(s):  
J. Ramnarain ◽  
H. Rashid ◽  
C. Dowling ◽  
J. Ramzy ◽  
R. Gooley

Angiology ◽  
2021 ◽  
pp. 000331972199223
Author(s):  
Jacqueline H. Morris ◽  
Junsoo Alex Lee ◽  
Scott McNitt ◽  
Ilan Goldenberg ◽  
Craig R. Narins

The activated clotting time (ACT) assay is used to monitor and titrate anticoagulation therapy with unfractionated heparin during percutaneous coronary intervention (PCI). Observations at our institution suggested a considerable difference between ACT values drawn from varying arterial sites, prompting the current study. Patients undergoing PCI with unfractionated heparin therapy were prospectively enrolled. Simultaneous arterial blood samples were drawn from the access sheath and the coronary guide catheter. Differences between Hemochron ACT values were determined, and potential interactions with clinical variables were analyzed. Immediately postprocedure, the simultaneous mean guide and sheath ACTs were 327 ± 62 seconds and 257 ± 44 seconds, respectively, with a mean difference of 70 ± 60 seconds (P < .001). Nearly all (90%) ACT values obtained via the guide catheter were higher than the concurrent ACT drawn from the sheath. Logistic regression analysis demonstrated that lower weight-adjusted heparin doses and absence of diabetes were associated with a greater difference between the ACT values. We conclude that the ACT value is substantially greater when assessed via the guide catheter versus the access sheath. Although the biological mechanisms require further study, this difference should be considered when managing anticoagulation during PCI and when reporting ACT as part of research protocols.


Perfusion ◽  
1996 ◽  
Vol 11 (2) ◽  
pp. 125-130 ◽  
Author(s):  
Ian J Reece ◽  
Gerrard Linley ◽  
Habib Al Tareif ◽  
Rollie DeVroege ◽  
Jitesh Tolia ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document